What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q2 2015?

86 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2015 13F Holders as of 30 Jun 2015

Security type / class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 43,473,000
Share change: +4,567,541
Total reported value: $179,861,198
Put/Call ratio: 28%
Reported price per share: $4.13
Number of holders: 86
Value change: +$18,861,290
Number of buys: 60
Number of sells: 32

Security key

14888U101

Report period

Q2 2015

Institutions

Top holders

CPRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2015 Previous quarter: Q1 2015 CATALYST PHARMACEUTICALS, INC. SEC filings CATALYST PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 14888U101

Newer quarter: Q3 2015 Previous quarter: Q1 2015

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

BAKER BROS. ADVISORS LP

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2015

13F Lead comparable stake: 6.1% Showing 1-6 of 15 holder rows.

Rank 1 holder

BAKER BROS. ADVISORS LP

13F

Ownership: 6.1%
Position: $32.76M

13F

Rank 2 holder

Point72 Asset Management, L.P.

13F

Ownership: 5.3%
Position: $28.44M

13F

Rank 3 holder

Consonance Capital Management LP

13F

Ownership: 3.9%
Position: $21M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BAKER BROS. ADVISORS LP	13F Company 13F	6.1%	$32,758,000 7,565,462 shares	—	31 Mar 2015
Point72 Asset Management, L.P.	13F Company 13F	5.3%	$28,439,000 6,568,000 shares	—	31 Mar 2015
Consonance Capital Management LP	13F Company 13F	3.9%	$21,000,000 4,849,870 shares	—	31 Mar 2015
Broadfin Capital, LLC	13F Company 13F	3.3%	$17,680,000 4,083,177 shares	—	31 Mar 2015
FRANKLIN RESOURCES INC	13F Company 13F	2%	$10,875,000 2,511,600 shares	—	31 Mar 2015
VANGUARD GROUP INC	13F Company 13F	1.8%	$9,650,000 2,228,589 shares	—	31 Mar 2015

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2015

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

43,473,000

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

Q2 2015 holders

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 value	Q2 2015 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend